Zini N, Neri L M, Ognibene A, Scotlandi K, Baldini N, Maraldi N M
Istituto di Citomorfologia Normale e Patologica, CNR, Bologna, Italy.
Microsc Res Tech. 1997 Feb 1;36(3):172-8. doi: 10.1002/(SICI)1097-0029(19970201)36:3<172::AID-JEMT5>3.0.CO;2-R.
The multidrug resistance (MDR) phenotype that is mediated by an overexpression of P-glycoprotein, has been suggested to be related also to an increased activity of protein kinase C (PKC) and to changes in phospholipid pattern. By electron microscope quantitative immunocytochemistry, we investigated whether PKC and other elements of the polyphosphoinositide signal transduction system are affected in an MDR variant of the human osteosarcoma cell line Saos-2. These cells, which are characterized by an increased expression of P-glycoprotein not only at the plasma membrane but also at the nuclear level, showed increased intranuclear amounts of phosphatidylinositol 4,5-bisphosphate and of phospholipase C beta 1, while both the amount and activity of both nuclear and cellular PKC were not modified with respect to sensitive cells. These results suggest that, in this model, the changes observed in the elements of nuclear signal transduction could be related to previously reported modifications of the MDR phenotype, but that P-glycoprotein phosphorylation is not dependent from increased PKC activity.
由P-糖蛋白过度表达介导的多药耐药(MDR)表型,也被认为与蛋白激酶C(PKC)活性增加以及磷脂模式变化有关。通过电子显微镜定量免疫细胞化学,我们研究了人骨肉瘤细胞系Saos-2的MDR变体中PKC和多磷酸肌醇信号转导系统的其他元件是否受到影响。这些细胞的特征不仅在于质膜上而且在核水平上P-糖蛋白表达增加,其核内磷脂酰肌醇4,5-二磷酸和磷脂酶Cβ1的量增加,而核和细胞PKC的量和活性相对于敏感细胞均未改变。这些结果表明,在该模型中,核信号转导元件中观察到的变化可能与先前报道的MDR表型改变有关,但P-糖蛋白磷酸化并不依赖于PKC活性的增加。